[Long-term study with kava special extract. Anxiety symptoms decrease over time].

S Lehrl; H Woelk

Home/Archive/PubMed

PubMed · 12119906

[Long-term study with kava special extract. Anxiety symptoms decrease over time].

S Lehrl·H Woelk

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Anxiety Arousal Follow-Up Studies Humans Phytotherapy Plant Extracts Randomized Controlled Trials as Topic Treatment Outcome Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

S Lehrl, H Woelk. 2002-06-06. [Long-term study with kava special extract. Anxiety symptoms decrease over time].. https://pubmed.ncbi.nlm.nih.gov/12119906/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Vagus nerve stimulation therapy: a research update.

Over the past 5 years, and especially within the last year, there has been a rapid expansion of vagus nerve stimulation (VNS)-related preclinical research, as well as clinical studies in indications other than epilepsy. The research advances in understanding VNS are occurring in the midst of a blossoming of other forms of therapeutic brain stimulation, such as electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and deep brain stimulation (DBS). In general, improved understanding of the neurobiological effects of VNS therapy as a function of the different use parameters (frequency, intensity, pulse width, duration, dose) is beginning to guide clinical use and help determine which diseases, in addition to epilepsy, VNS might treat.

Anxiety↗

PubMed2002

[Psychiatric sequelae of interferon-alpha therapy].

INTRODUCTION: Psychopathologic conditions commonly complicate the treatment with the interferon-alpha. The most important among them is depression, which can induce suicidal attempt. The outcome of mental side effects of interferon-alpha necessitate the discontinuation of therapy and, in more severe cases, psychiatric treatment. AIM AND METHOD: A brief literature review presents the biology of interferon-alpha with emphasis on the central nervous system effects which are probably closely related to mental side effects. Three case reports demonstrate the interdisciplinary nature of interferon induced psychiatric conditions. RESULTS: The appearance of neuropsychiatric side effects of interferon-alpha are frequent, the consequences of which can prove dramatic: involvement of the vital prognosis, psychiatric morbidity, especially depressions, and suicidal risk. CONCLUSION: The close collaboration of clinical practitioners and psychiatrists, from the pre-therapeutical evaluation to the follow up care is required.

Anxiety↗

PubMed2002

Fatigue.

Explore the source record for details and available documents.

Anxiety↗